GSK2656157: Mechanism of Action

GSK2656157 MOA:Targeting PERK/UPR for Oncology Research

🎯 check GSK2656157 product page

GSK2656157 is a potent, selective ATP-competitive PERK inhibitor. It affects the PERK-eIF2α-ATF4 and PERK-CHOP signaling pathways by downregulating phosphorylated PERK and CHOP expression, effectively inhibiting endoplasmic reticulum stress and apoptosis.

Primary Applications and Mechanism of Action